SYK coordinates neuroprotective microglial responses in neurodegenerative disease

Recent studies have begun to reveal critical roles for the brain's professional phagocytes, microglia, and their receptors in the control of neurotoxic amyloid beta (AD) and myelin debris accumulation in neurodegenerative disease. However, the critical intracellular molecules that orchestrate neuroprotective functions of microglia remain poorly understood. In our studies, we find that targeted deletion of SYK in microglia leads to exacer-bated AD deposition, aggravated neuropathology, and cognitive defects in the 5xFAD mouse model of Alz-heimer's disease (AD). Disruption of SYK signaling in this AD model was further shown to impede the devel-opment of disease-associated microglia (DAM), alter AKT/GSK3D-signaling, and restrict AD phagocytosis by microglia. Conversely, receptor-mediated activation of SYK limits AD load. We also found that SYK critically regulates microglial phagocytosis and DAM acquisition in demyelinating disease. Collectively, these results broaden our understanding of the key innate immune signaling molecules that instruct beneficial microglial functions in response to neurotoxic material.

Automated summary

Recent studies have highlighted the critical roles of microglia and their receptors in controlling neurotoxic material in neurodegenerative diseases. SYK plays an important role in neuroprotective functions of microglia, with its deletion exacerbating AD deposition and neuropathology. In addition, SYK regulates microglial phagocytosis and DAM acquisition in demyelinating disease.